Similar articles

• Editorial comment.

  Williams SG. Williams SG. J Urol. 2010 Feb;183(2):639; discussion 639-40. doi: 10.1016/j.juro.2009.09.093. Epub 2009 Dec 16. J Urol. 2010. PMID: 20018309 No abstract available.
• Does neoadjuvant hormonal therapy improve urinary function when given to men with large prostates undergoing prostate brachytherapy?

  Stone NN, Marshall DT, Stone JJ, Cesaretti JA, Stock RG. Stone NN, et al. J Urol. 2010 Feb;183(2):634-9. doi: 10.1016/j.juro.2009.09.084. Epub 2009 Dec 16. J Urol. 2010. PMID: 20018308
• Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy.

  Mabjeesh NJ, Chen J, Stenger A, Matzkin H. Mabjeesh NJ, et al. Urology. 2007 Sep;70(3):548-53. doi: 10.1016/j.urology.2007.04.042. Urology. 2007. PMID: 17905113
• [New anti-androgen and luteinizing hormone releasing hormone antagonist for the treatment of advanced prostate cancer].

  Furuya Y, Masai M. Furuya Y, et al. Nihon Rinsho. 2000 Jul;58 Suppl:317-9. Nihon Rinsho. 2000. PMID: 11022739 Review. Japanese. No abstract available.
• [Neoadjuvant androgen ablation therapy (NAT)].

  Kanetake H, Igawa T. Kanetake H, et al. Nihon Rinsho. 2000 Jul;58 Suppl:320-2. Nihon Rinsho. 2000. PMID: 11022740 Review. Japanese. No abstract available.